Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:306431D84.8
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies is a rare condition in which the body's immune system mistakenly produces antibodies that block interferon-gamma, a key protein that helps fight infections. Interferon-gamma is essential for activating certain white blood cells (especially macrophages) that defend against bacteria, fungi, and other organisms that live inside cells. When these antibodies neutralize interferon-gamma, the immune system becomes severely weakened, leaving patients vulnerable to unusual and hard-to-treat infections. This condition typically appears in previously healthy adults, usually between the ages of 30 and 60. Patients often develop infections caused by organisms that rarely cause disease in people with normal immune systems, known as opportunistic infections. The most common infections involve nontuberculous mycobacteria (NTM), which can affect the lymph nodes, bones, joints, lungs, and skin. Patients may also develop infections from fungi like Talaromyces (Penicillium) marneffei, Cryptococcus, Histoplasma, and other unusual organisms such as Salmonella or Burkholderia. Symptoms often include recurring fevers, swollen lymph nodes, skin lesions, bone pain, persistent cough, weight loss, and night sweats. Treatment involves long-term use of multiple antibiotics or antifungal medications to control infections. In some cases, doctors use therapies to reduce the harmful autoantibodies, such as rituximab (a medication that targets the immune cells producing the antibodies) or cyclophosphamide. Despite treatment, infections tend to recur, and managing this condition requires ongoing medical care from specialists experienced with immunodeficiency disorders.

Also known as:

Key symptoms:

Recurring fevers that don't go away with usual treatmentSwollen lymph nodes in multiple areas of the bodySkin lumps, abscesses, or non-healing skin lesionsPersistent cough or lung infectionsBone or joint pain from deep infectionsUnexplained weight lossNight sweatsFatigue and general feeling of being unwellInfections caused by unusual organisms (opportunistic infections)Soft tissue abscessesRecurrent bloodstream infectionsSwelling or masses in the abdomen

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.

View clinical trials →

No actively recruiting trials found for Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies community →

Specialists

3 foundView all specialists →
CP
Chusana Suankratay, M.D., Ph.D.
Specialist
PI on 1 active trial
WM
Warat Usawakidwiree, M.D.
Specialist
PI on 1 active trial
NA
Nasikarn Angkasekwinai
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Adult-onset immunodeficiency with anti-interferon-gamma autoantibodiesForum →

No community posts yet. Be the first to share your experience with Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.

Start the conversation →

Latest news about Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies

No recent news articles for Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific infections do I have, and what organisms are causing them?,How long will I need to take antibiotics or antifungal medications?,Am I a candidate for rituximab or other treatments to reduce my autoantibodies?,How often will I need blood tests and imaging to monitor my condition?,Are there activities or environments I should avoid to reduce my risk of new infections?,What symptoms should prompt me to seek emergency care?,Are there clinical trials or research studies I could participate in?

Common questions about Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies

What is Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies?

Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies is a rare condition in which the body's immune system mistakenly produces antibodies that block interferon-gamma, a key protein that helps fight infections. Interferon-gamma is essential for activating certain white blood cells (especially macrophages) that defend against bacteria, fungi, and other organisms that live inside cells. When these antibodies neutralize interferon-gamma, the immune system becomes severely weakened, leaving patients vulnerable to unusual and hard-to-treat infections. This condition typically appe

How is Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies inherited?

Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies typically begin?

Typical onset of Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies is adult. Age of onset can vary across affected individuals.

Which specialists treat Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies?

3 specialists and care centers treating Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.